Ranbaxy Laboratories shares gained on Monday after Nomura upgraded the stock to buy from neutral.
Ranbaxy shares ended 1.2 per cent higher at 407.65 on BSE. During the day, the shares traded between 405.75 and 412.55.
Reports quoting a Nomura note cited
FDA approvals for key drugs and the organisational restructuring exercise as positive catalysts for the stock.
On Monday, the broader markets ended flat with Sensex ending 37 points lower at 19646.21.
Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Special 
